Abstract
The serum level of tumour-antigen 4 (TA-4) was measured in 181 patients with squamous cell carcinoma (SCC) of various organs (71 lung, 24 uterus, 16 oesophagus, 64 head and neck and six skin), 34 patients with other types of lung cancer and 35 patients with benign diseases. To compare the results with those obtained by the conventional competitive radioimmunoassay (RIA) using a polyclonal antibody, a new immunoradiometric assay (IRMA) method was used which has recently been developed using two monoclonal antibodies raised to different epitopes of TA-4. Both methods provided essentially the same results: the serum TA-4 levels were high in patients with SCC of various organs when compared with those of healthy controls and patients with other types of lung cancer or benign diseases. However, the positive ratios assessed as the percentage of patients with elevated serum TA-4 levels were higher with the IRMA method than with the RIA method in SCC of all organs, as much as 2-3 times higher in SCC of the larynx, tongue and pharynx. In contrast, in patients with benign diseases or other types of lung cancer, there was no difference in the positive ratios between the two methods. This was largely due to the improvement in sensitivity and accuracy of assay with the new method, which resulted in a decrease in the normal value in healthy controls. It was concluded that with the new IRMA method using monoclonal antibodies, the diagnostic detectability of serum TA-4 is enhanced in SCC of all organs.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ehrlich P. H., Moyle W. R. Cooperative immunoassays: ultrasensitive assays with mixed monoclonal antibodies. Science. 1983 Jul 15;221(4607):279–281. doi: 10.1126/science.6857284. [DOI] [PubMed] [Google Scholar]
- Kato H., Miyauchi F., Morioka H., Fujino T., Torigoe T. Tumor antigen of human cervical squamous cell carcinoma: correlation of circulating levels with disease progress. Cancer. 1979 Feb;43(2):585–590. doi: 10.1002/1097-0142(197902)43:2<585::aid-cncr2820430227>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
- Kato H., Morioka H., Aramaki S., Tamai K., Torigoe T. Prognostic significance of the tumor antigen TA-4 in squamous cell carcinoma of the uterine cervix. Am J Obstet Gynecol. 1983 Feb 1;145(3):350–354. doi: 10.1016/0002-9378(83)90723-8. [DOI] [PubMed] [Google Scholar]
- Kato H., Morioka H., Tsutsui H., Aramaki S., Torigoe T. Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer. Cancer. 1982 Oct 1;50(7):1294–1296. doi: 10.1002/1097-0142(19821001)50:7<1294::aid-cncr2820500712>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
- Kato H., Nagaya T., Torigoe T. Heterogeneity of a tumor antigen TA-4 of squamous cell carcinoma in relation to its appearance in the circulation. Gan. 1984 May;75(5):433–435. [PubMed] [Google Scholar]
- Kato H., Tamai K., Morioka H., Nagai M., Nagaya T., Torigoe T. Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinoma. Cancer. 1984 Oct 15;54(8):1544–1546. doi: 10.1002/1097-0142(19841015)54:8<1544::aid-cncr2820540813>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
- Kato H., Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer. 1977 Oct;40(4):1621–1628. doi: 10.1002/1097-0142(197710)40:4<1621::aid-cncr2820400435>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
- Maruo T., Shibata K., Kimura A., Hoshina M., Mochizuki M. Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization. Cancer. 1985 Jul 15;56(2):302–308. doi: 10.1002/1097-0142(19850715)56:2<302::aid-cncr2820560217>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
- Mino N., Iio A., Hamamoto K. Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs. Cancer. 1988 Aug 15;62(4):730–734. doi: 10.1002/1097-0142(19880815)62:4<730::aid-cncr2820620415>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]